Recent news on Symbyax

Lilly to join wider drug warning  -  May 3, 2007
Indianapolis Star,They will apply to an entire class of 36 antidepressants, including three sold by Lilly: Cymbalta, Prozac and Symbyax. Other medicines affected by the FDA

Antidepressants linked to suicide risk in young adults  -  May 5, 2007
Food Consumer,Remeron (mirtazapine), Sarafem (fluoxetine HCl), Seroquel (quetiapine), Sinequan (doxepin), Surmontil (trimipramine), Symbyax (olanzapine/fluoxetine),

FDA - all antidepressants need new warning labels  -  May 3, 2007
News-Medical.net,Paxil, Pexeva, Prozac, Remeron Sarafem, Seroquel, Sinequan, Surmontil, Symbyax, Tofranil, Tofranil-PM, Triavil, Vivactil, Wellbutrin, Zoloft and Zyban.

Research & Markets: Only Eli Lilly's Symbyax and AstraZeneca's ...  -  Apr 5, 2007
Genetic Engineering News (press release),While lithium and several antiepileptic and antipsychotic agents are currently used to treat either manic or mixed episodes of BPD, only Eli Lilly's Symbyax

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
MSN MoneyIn March, Lilly received an approvable letter from the US FDA for a treatment-resistant depression (TRD) indication for Symbyax. Lilly is currently working

Analysis: Mixed views on Lilly's strong Q1  -  Apr 16, 2007
United Press International..."Lilly announced today that they have received an 'approvable' for Symbyax (a combination of Zyprexa and Prozac) in use for treatment resistant depression,

Lilly First-Quarter Profit Falls on Icos Purchase (Update3)  -  Apr 16, 2007
BloombergLilly said today that US regulators delayed approval until at least the second half of the year for Symbyax, a drug that combines Zyprexa and the depression

Fitch Rates Eli Lilly & Co.'s $2.5B Senior Notes 'AA'  -  Mar 8, 2007
Business Wire (press release),The program (and that of its partners) has yielded the commercialization of Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris,

FDA handling of Lilly drug needs probe: scientist  -  Feb 13, 2007
ABC NewsAntipsychotics include Bristol-Myers Squibb's Abilify, Novartis AG's Clozaril, Lilly's Symbyax, AstraZeneca Plc's Seroquel, Johnson & Johnson's Risperdal

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Earthtimes.orgNewer products -- Alimta(R), Byetta(R), Cialis(R), Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and Yentreve(R) -- collectively grew 41

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Yahoo! News (press release)Newer products -- Alimta®, Byetta®, Cialis®, Cymbalta®, Forteo®, Strattera®, Symbyax®, Xigris® and Yentreve® -- collectively grew 41 percent,

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
Yahoo! News (press release)...fibromyalgia and chronic pain, a treatment-resistant depression indication for Symbyax®, a first-line non-small-cell lung cancer indication for Alimta

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
PR Newswire (press release),...depression indication for Symbyax(R), a first-line non-small-cell lung cancer indication for Alimta and a long-acting release formulation for Byetta.

Eli Lilly Reaffirms FY06 Outlook; Guides FY07; Sees ICOS ...  -  Dec 7, 2006
Trading Markets,...new indications for Cymbalta including general anxiety disorder, fibromyalgia and chronic pain, a treatment-resistant depression indication for Symbyax,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional